A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT02031458 · COMPLETED
Trial details
- NCT number
- NCT02031458
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-22
- Primary completion
- 2015-05-28
- Enrollment
- 667
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.